NCT00892203 - Efficacy and Safety of BGG492 in the Treatment of Migraine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Migraine

Interventions

DRUG

BGG492

DRUG

Sumatriptan

DRUG

Placebo

Trial Locations (13)

California Clinical Trials, 15625 Lakewood Boulevard, Paramount

California Clinical Trials, 1560 Chevy Chase Drive, Suite 140, Glendale

Novartis Investigative Site, Berlin

Novartis Investigative Site, Essen

Novartis Investigative Site, Göttingen

Novartis Investigator Site, Hamburg

Novartis Investigative Site, Kiel

Novartis Investigative Site, Königstein

Novartis Investigative Site, Munich

Novartis Investigator Site, Munich

Novartis Investigative Site, Münster

Novartis Investigative Site, Würzburg

Novartis Investigative Site, Barcelona